<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Familial <z:hpo ids='HP_0001639'>hypertrophic cardiomyopathy</z:hpo> (HCM) isÂ a prevalent hereditary <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">cardiac disorder</z:e> linked to <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> and <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>While the causes of HCM have been identified as genetic mutations in the cardiac sarcomere, the pathways by which sarcomeric mutations engender myocyte <z:mpath ids='MPATH_159'>hypertrophy</z:mpath> and electrophysiological abnormalities are not understood </plain></SENT>
<SENT sid="2" pm="."><plain>To elucidate the mechanisms underlying HCM development, we generated patient-specific induced pluripotent stem cell cardiomyocytes (iPSC-CMs) from a ten-member family cohort carrying a hereditary HCM missense mutation (Arg663His) in the MYH7 gene </plain></SENT>
<SENT sid="3" pm="."><plain>Diseased iPSC-CMs recapitulated numerous aspects of the HCM phenotype including cellular enlargement and contractile <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> at the single-cell level </plain></SENT>
<SENT sid="4" pm="."><plain>Calcium (Ca(2+)) imaging indicated dysregulation of Ca(2+) cycling and elevation in intracellular Ca(2+) ([Ca(2+)](i)) are central mechanisms for disease pathogenesis </plain></SENT>
<SENT sid="5" pm="."><plain>Pharmacological restoration of Ca(2+) homeostasis prevented development of <z:mpath ids='MPATH_159'>hypertrophy</z:mpath> and electrophysiological irregularities </plain></SENT>
<SENT sid="6" pm="."><plain>We anticipate that these findings will help elucidate the mechanisms underlying HCM development and identify novel therapies for the disease </plain></SENT>
</text></document>